Parker, Lauren E
Jones, Jace W
Papanicolaou, Kyriakos N
Talbot, C Conover
Margulies, Kenneth B
Kane, Maureen A
Foster, D Brian
PublisherAmerican Society for Clinical Investigation
MetadataShow full item record
AbstractAlthough low circulating levels of the vitamin A metabolite, all-trans retinoic acid (ATRA), are associated with increased risk of cardiovascular events and all-cause mortality, few studies have addressed whether cardiac retinoid levels are altered in the failing heart. Here, we showed that proteomic analyses of human and guinea pig heart failure (HF) were consistent with a decline in resident cardiac ATRA. Quantitation of the retinoids in ventricular myocardium by mass spectrometry revealed 32% and 39% ATRA decreases in guinea pig HF and in patients with idiopathic dilated cardiomyopathy (IDCM), respectively, despite ample reserves of cardiac vitamin A. ATRA (2 mg/kg/d) was sufficient to mitigate cardiac remodeling and prevent functional decline in guinea pig HF. Although cardiac ATRA declined in guinea pig HF and human IDCM, levels of certain retinoid metabolic enzymes diverged. Specifically, high expression of the ATRA-catabolizing enzyme, CYP26A1, in human IDCM could dampen prospects for an ATRA-based therapy. Pertinently, a pan-CYP26 inhibitor, talarozole, blunted the impact of phenylephrine on ATRA decline and hypertrophy in neonatal rat ventricular myocytes. Taken together, we submit that low cardiac ATRA attenuates the expression of critical ATRA-dependent gene programs in HF and that strategies to normalize ATRA metabolism, like CYP26 inhibition, may have therapeutic potential. © 2021, Yang et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/15719
- Inhibition of the <i>all-trans</i> Retinoic Acid (<i>at</i>RA) Hydroxylases CYP26A1 and CYP26B1 Results in Dynamic, Tissue-Specific Changes in Endogenous <i>at</i>RA Signaling.
- Authors: Stevison F, Hogarth C, Tripathy S, Kent T, Isoherranen N
- Issue date: 2017 Jul
- CYP26B1 plays a major role in the regulation of all-trans-retinoic acid metabolism and signaling in human aortic smooth muscle cells.
- Authors: Ocaya PA, Elmabsout AA, Olofsson PS, Törmä H, Gidlöf AC, Sirsjö A
- Issue date: 2011
- CYP26C1 Is a Hydroxylase of Multiple Active Retinoids and Interacts with Cellular Retinoic Acid Binding Proteins.
- Authors: Zhong G, Ortiz D, Zelter A, Nath A, Isoherranen N
- Issue date: 2018 May
- Molecular targeting of retinoic acid metabolism in neuroblastoma: the role of the CYP26 inhibitor R116010 in vitro and in vivo.
- Authors: Armstrong JL, Taylor GA, Thomas HD, Boddy AV, Redfern CP, Veal GJ
- Issue date: 2007 Jun 4
- Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells.
- Authors: Ozpolat B, Mehta K, Lopez-Berestein G
- Issue date: 2005 Oct